High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load
Authors:
Open Access
- 17 December 2022
- journal article
- research article
- Published by Springer Nature in International Microbiology
- Vol. 26 (3) , 471-474
Abstract
ADVIA Centaur SARS-CoV-2 Antigen (COV2Ag) Assay (Siemens Healthineers) was evaluated for SARS-CoV-2 detection. A total of 141 nasopharyngeal samples were analyzed by this technique and results were compared with those obtained by quantitative reverse-transcription polymerase chain reaction (RT-PCR). The overall sensitivity and specificity of the test were 68.70% and 70%, respectively. Regarding cycle threshold (Ct) values, the COV2Ag test showed a sensitivity of 93.75% and 100% for nasopharyngeal samples with Ct < 25 and < 20, respectively. ADVIA Centaur COV2Ag Assay is a useful, automated, and rapid technique for early SARS-CoV-2 diagnosis and isolation of the infected individuals, avoiding its transmission.Keywords
This publication has 8 references indexed in Scilit:
- Performance of High Throughput SARS-CoV-2 Antigen Testing Compared to Nucleic Acid TestingLaboratory Medicine, 2022
- Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assayClinical Chemistry and Laboratory Medicine (CCLM), 2022
- Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infectionBMC Infectious Diseases, 2022
- Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-AnalysisDiagnostics, 2022
- Diagnostic Performance of Automated SARS-CoV-2 Antigen Assay in Nasal Swab during COVID-19 Vaccination CampaignDiagnostics, 2021
- Diagnostics for SARS-CoV-2 infectionsNature Materials, 2021
- COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines2021
- Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patientsInternational Journal of Infectious Diseases, 2020